{
  "ticker": "ALVO",
  "company_name": "Alvotech",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03983876",
      "title": "PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Phase 1",
      "start_date": "2019-07-01",
      "completion_date": "2019-12-03",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT06570772",
      "title": "Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Ulcerative Colitis",
      "start_date": "2024-09-23",
      "completion_date": "2025-11-25",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT06400719",
      "title": "Pilot Study of AVT16 in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2024-05-29",
      "completion_date": "2024-11-06",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT03579823",
      "title": "Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2018-05-21",
      "completion_date": "2018-08-24",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT05986786",
      "title": "Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Chorioretinal Vascular Disease",
      "start_date": "2024-02-28",
      "completion_date": "2025-03-21",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT04930042",
      "title": "Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Psoriasis",
      "start_date": "2021-06-03",
      "completion_date": "2022-10-11",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT03849404",
      "title": "Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Plaque Psoriasis",
      "start_date": "2019-02-20",
      "completion_date": "2020-07-20",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT04224194",
      "title": "Auto-injector Real Life Handling in Patients",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "RA",
      "start_date": "2019-11-04",
      "completion_date": "2021-02-26",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT05632211",
      "title": "A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi\u00ae in Healthy Adult Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Adult Subjects",
      "start_date": "2022-12-16",
      "completion_date": "2023-10-03",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    },
    {
      "nct_id": "NCT06732804",
      "title": "Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Male and Female Subjects",
      "start_date": "2025-02-11",
      "completion_date": "2026-01-08",
      "enrollment": 0,
      "sponsor": "Alvotech Swiss AG"
    }
  ],
  "summary": {
    "total_trials": 18,
    "by_phase": {
      "PHASE1": 9,
      "PHASE3": 9
    },
    "by_status": {
      "COMPLETED": 17,
      "TERMINATED": 1
    },
    "active_trials": 0,
    "completed_trials": 17,
    "conditions": [
      "Chorioretinal Vascular Disease",
      "Healthy",
      "Healthy Adult Subjects",
      "Healthy Male Subjects",
      "Healthy Male and Female Subjects",
      "Healthy Volunteers",
      "Neovascular (Wet) AMD",
      "Osteoporosis, Postmenopausal",
      "Phase 1",
      "Plaque Psoriasis",
      "Psoriasis",
      "RA",
      "Rheumatoid Arthritis",
      "This is a Phase I Study Conducted in Healthy Volunteers",
      "Ulcerative Colitis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:16.115121",
    "search_query": "Alvotech",
    "url": "https://clinicaltrials.gov/search?term=Alvotech"
  }
}